Literature DB >> 8800996

Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy.

U Kühl1, M Noutsias, B Seeberg, H P Schultheiss.   

Abstract

OBJECTIVE: To determine whether immunohistochemical analysis of cardiac biopsies from patients presenting clinically as dilated cardiomyopathy (DCM) show a chronic inflammatory process.
DESIGN: Comparative case control study.
SETTING: Tertiary referral centre. PATIENTS: Biopsies from 170 patients with DCM and 85 control patients with other cardiac diseases.
RESULTS: Nine patients had sufficient interstitial inflammatory cells to be called borderline myocarditis on conventional histology, leaving 161 patients with DCM. In 78 patients with DCM (48%) there were T lymphocytes in the myocardium. In 48 (62%) of these 78 T lymphocyte densities were in the range 2-14 per high power field (HPF), equivalent to 7-50 per mm2 of tissue. In 43 (89%) interstitial and endothelial immune activation was demonstrated by MHC expression. In 30 patients with T cell counts in the range 1.5-2.0 per HPF, 80% also showed endothelial activation. Lymphocyte density correlated with increased expression of MHC class I and II antigens and the adhesion molecules ICAM, VCAM, ELAM, LFA-3, and GMP140. In all control biopsies the T lymphocyte density was less than 1.0 per HPF (less than 2-5 per mm2 of tissue).
CONCLUSIONS: Nearly half the patients with DCM had increased T lymphocyte density and immune activation of endothelial and interstitial cells in their cardiac biopsies. A chronic autoimmune process is still active within the myocardium in a significant percentage of patients with DCM. Immunohistochemical analysis of cardiac biopsies will enhance the sensitivity of cardiac biopsy and is essential for the diagnosis of myocarditis.

Entities:  

Mesh:

Year:  1996        PMID: 8800996      PMCID: PMC484290          DOI: 10.1136/hrt.75.3.295

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  25 in total

Review 1.  The challenge of cardiomyopathy.

Authors:  W H Abelmann; B H Lorell
Journal:  J Am Coll Cardiol       Date:  1989-05       Impact factor: 24.094

2.  Myocarditis. A histopathologic definition and classification.

Authors:  H T Aretz; M E Billingham; W D Edwards; S M Factor; J T Fallon; J J Fenoglio; E G Olsen; F J Schoen
Journal:  Am J Cardiovasc Pathol       Date:  1987-01

3.  Myocarditis: the Dallas criteria.

Authors:  H T Aretz
Journal:  Hum Pathol       Date:  1987-06       Impact factor: 3.466

4.  Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy.

Authors:  C J Limas; I F Goldenberg; C Limas
Journal:  Circ Res       Date:  1989-01       Impact factor: 17.367

5.  Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function.

Authors:  K Schulze; B F Becker; R Schauer; H P Schultheiss
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

6.  Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error.

Authors:  A J Hauck; D L Kearney; W D Edwards
Journal:  Mayo Clin Proc       Date:  1989-10       Impact factor: 7.616

7.  Interobserver variability in the pathologic interpretation of endomyocardial biopsy results.

Authors:  J G Shanes; J Ghali; M E Billingham; V J Ferrans; J J Fenoglio; W D Edwards; C C Tsai; J E Saffitz; J Isner; S Furner
Journal:  Circulation       Date:  1987-02       Impact factor: 29.690

8.  Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy.

Authors:  N E Bowles; P J Richardson; E G Olsen; L C Archard
Journal:  Lancet       Date:  1986-05-17       Impact factor: 79.321

9.  Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis.

Authors:  P G Wolff; U Kühl; H P Schultheiss
Journal:  Am Heart J       Date:  1989-06       Impact factor: 4.749

10.  Antibody-mediated enhancement of calcium permeability in cardiac myocytes.

Authors:  H P Schultheiss; U Kühl; I Janda; B Melzner; G Ulrich; M Morad
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

View more
  56 in total

Review 1.  The cardiomyopathies: an overview.

Authors:  M J Davies
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

2.  Functional and biochemical characteristics of mitochondrial fractions from rat liver in cold-induced oxidative stress.

Authors:  P Venditti; R De Rosa; G Caldarone; S Di Meo
Journal:  Cell Mol Life Sci       Date:  2004-12       Impact factor: 9.261

3.  Foreword to special issue on "Myocarditis".

Authors:  Alida L P Caforio
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

4.  A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy.

Authors:  Carlos Gorbea; Kimberly A Makar; Matthias Pauschinger; Gregory Pratt; Jeathrina L F Bersola; Jacquelin Varela; Ryan M David; Lori Banks; Chien-Hua Huang; Hua Li; Heinz-Peter Schultheiss; Jeffrey A Towbin; Jesús G Vallejo; Neil E Bowles
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

5.  Recent-onset dilated cardiomyopathy associated with Borrelia burgdorferi infection.

Authors:  Petr Kuchynka; Tomas Palecek; Stepan Havranek; Ivana Vitkova; Eduard Nemecek; Radka Trckova; Dagmar Berenová; Daniel Krsek; Jana Podzimkova; Michal Fikrle; Barbara Anna Danek; Ales Linhart
Journal:  Herz       Date:  2015-05-05       Impact factor: 1.443

Review 6.  [Inflammatory cardiac diseases by primary extracardial diseases].

Authors:  M Brehm; P Rellecke; B E Strauer
Journal:  Internist (Berl)       Date:  2008-01       Impact factor: 0.743

Review 7.  Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease.

Authors:  Cristina Basso; Fiorella Calabrese; Annalisa Angelini; Elisa Carturan; Gaetano Thiene
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

8.  Increases in circulating T lymphocytes expressing HLA-DR and CD40 ligand in patients with dilated cardiomyopathy.

Authors:  Atsuko Ueno; Kagari Murasaki; Nobuhisa Hagiwara; Hiroshi Kasanuki
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

9.  Correlation of epicardial and systemic flow-mediated vasodilation in patients with atypical angina but no evidence of atherosclerotic disease.

Authors:  Katja B Vallbracht-Israng; Andreas Morguet; Peter L Schwimmbeck
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

10.  Presence of Borrelia burgdorferi in endomyocardial biopsies in patients with new-onset unexplained dilated cardiomyopathy.

Authors:  Tomas Palecek; Petr Kuchynka; Dagmar Hulinska; Jana Schramlova; Hana Hrbackova; Ivana Vitkova; Stanislav Simek; Jan Horak; William E Louch; Ales Linhart
Journal:  Med Microbiol Immunol       Date:  2010-01-06       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.